Profile of Cardiovascular Risk Factors and Mortality in Patients with Symptomatic Peripheral Arterial Disease

Clinics - Tập 64 - Trang 323-326 - 2009
Silméia Garcia Zanati1, Guilherme Grisi Mouraria1, Luiz Shigero Matsubara1, Mariângela Giannini2, Beatriz B Matsubara1
1Department of Internal Medicine, Botucatu Medical School - Botucatu/SP, Brazil
2Department of Surgery, Botucatu Medical School - Botucatu/SP, Brazil

Tài liệu tham khảo

Ouriel, 2001, Peripheral artery disease, Lancet, 358, 1257, 10.1016/S0140-6736(01)06351-6

Belch, 2003, Critical issues in peripheral arterial disease detection and management. A call for action, Arch Intern Med, 163, 884, 10.1001/archinte.163.8.884

Murabito, 1997, Intermitent claudication: a risk profile from the Framingham Heart Study, Circulation, 96, 1, 10.1161/01.CIR.96.1.44

Strong, 1992, Atherosclerosis lesions. Natural history, risk factors and topography, Arch Pathol Lab Med, 116, 1268

Janes, 2008, Pharmacological secondary prevention in people with peripheral arterial disease compared to those with coronary artery disease: a missed opportunity, Br J Cardiol, 15, 48

Hirsch, 2001, The Minnesota regional peripheral arterial disease screening program: toward a definition of community standards of care, Vasc Med, 6, 87, 10.1177/1358836X0100600204

Faxon, 2004, Atherosclerotic Vascular Disease Conference. Executive Summary: Atherosclerotic Vascular Disease Conference Proceeding for Healthcare Professionals From a Special Writing Group of the American Heart Association, Circulation, 109, 2595, 10.1161/01.CIR.0000128517.52533.DB

Grundy, 1999, Diabetes and Cardiovascular Disease: a Statement for Healthcare Professionals from the American Heart Association, Circulation, 100, 1134, 10.1161/01.CIR.100.10.1134

Mukherjee, 2002, Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2), Circulation, 106, 1909, 10.1161/01.CIR.0000035649.39669.CE

Smith, 2006, J Am Coll Cardiol, 47, 2130, 10.1016/j.jacc.2006.04.026

Lang, 2005, J Am Soc Echocardiogr, 18, 1440, 10.1016/j.echo.2005.10.005

Faulkner, 1983, The effect of cessation of smoking on the accumulative survival rates of patients with symptomatic peripheral vascular disease, Med J Aust, 1, 217, 10.5694/j.1326-5377.1983.tb99395.x

2001

Wachtel, 2001, Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (the LIFE Study), Am J Cardiol, 87, 54, 10.1016/S0002-9149(00)01272-8

Kitzman, 2001, Importance of Heart Failure with Preserved Systolic Function in patients after 65 years of age, Am J Cardiol, 87, 413, 10.1016/S0002-9149(00)01393-X

Hertzer, 1984, Coronary artery disease in peripheral vascular patients: a classification of 1000 coronary angiograms and results of surgical management, Ann Surg, 199, 223, 10.1097/00000658-198402000-00016